percent of americans on glp 1 US Obesity Rates Have Dropped, And GLP-1 Drugs May Explain Why : ScienceAlert GLP-1 Survey: 75% of Users
Description
bimagrumab) may improve the body composition during WL and are in early phase clinical trials
/images/2025/03/06/80a97023-8cda-4f9b-9f34-acfd82496b14.png)
Listen now (47 mins) |
Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug spending

California insurance bad faith attorneys Gianelli & Morris report on nationwide practice of health plans dropping coverage for FDA-approved weight loss drugs.

A recent study links use of weight-loss drugs like Ozempic, Wegovy, Rybelsus, Trulicity, Mounjaro, or Zepbound to vision loss in patients.

Understanding your genetic predispositions and biomarker profile may help inform personalized treatment decisions with your provider
